These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32075312)

  • 1. Plasma Lysyl-tRNA Synthetase 1 (KARS1) as a Novel Diagnostic and Monitoring Biomarker for Colorectal Cancer.
    Suh JH; Park MC; Goughnour PC; Min BS; Kim SB; Lee WY; Cho YB; Cheon JH; Lee KY; Nam DH; Kim S
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32075312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases.
    Lee DH; Paik ES; Cho YJ; Lee YY; Lee B; Lee EJ; Choi JJ; Choi CH; Lee S; Choi JW; Lee JW
    Cancer Biomark; 2022; 35(1):99-109. PubMed ID: 35912727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of the phenotypic spectrum of KARS1-related disorders to include arthrogryposis multiplex congenita and summary of experiences with lysine supplementation.
    Bejma TA; Beidler WS; VanSickle EA; Prokop JW; Brown WT; Scheurer-Monaghan A; Rossetti LZ
    Am J Med Genet A; 2024 Jul; ():e63811. PubMed ID: 38980148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease.
    Cappuccio G; Ceccatelli Berti C; Baruffini E; Sullivan J; Shashi V; Jewett T; Stamper T; Maitz S; Canonico F; Revah-Politi A; Kupchik GS; Anyane-Yeboa K; Aggarwal V; Benneche A; Bratland E; Berland S; D'Arco F; Alves CA; Vanderver A; Longo D; Bertini E; Torella A; Nigro V; ; D'Amico A; van der Knaap MS; Goffrini P; Brunetti-Pierri N
    Hum Mutat; 2021 Jun; 42(6):745-761. PubMed ID: 33942428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Deficiency in Patients with Biallelic KARS1 Mutations.
    Saettini F; Guerra F; Fazio G; Bugarin C; McMillan HJ; Ohtake A; Ardissone A; Itoh M; Giglio S; Cappuccio G; Giardino G; Romano R; Quadri M; Gasperini S; Moratto D; Chiarini M; Akira I; Fukuhara Y; Hayakawa I; Okazaki Y; Mauri M; Piazza R; Cazzaniga G; Biondi A
    J Clin Immunol; 2023 Nov; 43(8):2115-2125. PubMed ID: 37770806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
    Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
    [No Abstract]   [Full Text] [Related]  

  • 8. Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish.
    Lin SJ; Vona B; Barbalho PG; Kaiyrzhanov R; Maroofian R; Petree C; Severino M; Stanley V; Varshney P; Bahena P; Alzahrani F; Alhashem A; Pagnamenta AT; Aubertin G; Estrada-Veras JI; Hernández HAD; Mazaheri N; Oza A; Thies J; Renaud DL; Dugad S; McEvoy J; Sultan T; Pais LS; Tabarki B; Villalobos-Ramirez D; Rad A; ; Galehdari H; Ashrafzadeh F; Sahebzamani A; Saeidi K; Torti E; Elloumi HZ; Mora S; Palculict TB; Yang H; Wren JD; Ben Fowler ; Joshi M; Behra M; Burgess SM; Nath SK; Hanna MG; Kenna M; Merritt JL; Houlden H; Karimiani EG; Zaki MS; Haaf T; Alkuraya FS; Gleeson JG; Varshney GK
    Genet Med; 2021 Oct; 23(10):1933-1943. PubMed ID: 34172899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice.
    Song CH; Kim N; Lee SM; Nam RH; Choi SI; Kang SR; Shin E; Lee DH; Lee HN; Surh YJ
    Biochem Pharmacol; 2019 Jun; 164():139-151. PubMed ID: 30981879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.
    Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M
    Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The germ-free mice monocolonization with
    Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
    Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
    Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
    Li L; Zhang L; Tian Y; Zhang T; Duan G; Liu Y; Yin Y; Hua D; Qi X; Mao Y
    Front Oncol; 2019; 9():921. PubMed ID: 31649870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
    Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
    J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0007534 as a blood-based marker for the diagnosis of colorectal cancer and its prognostic value.
    Zhang W; Yang S; Liu Y; Wang Y; Lin T; Li Y; Zhang R
    Int J Clin Exp Pathol; 2018; 11(3):1399-1406. PubMed ID: 31938236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.